drugset / Trial / NCT02542592

Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients

NCT02542592

Phase 2/3 Completed 64 enrolled Rigshospitalet, Denmark Bispebjerg Hospital · collab
RandomizedParallel-groupQuadruple-blind

Summary

The study evaluates the pathophysiological effects of a single dose Methylprednisolone administered prior to total hip-arthroplasty (THA) surgery. The investigators examine the effect on immune signaling and recovery after surgery. Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will receive placebo. The investigators hypothesize that the group receiving Methylprednisolone will experience a positive modulation of the immune response and an enhanced recovery.

Timeline

Start
2015-09
Primary completion
2017-01
Completion
2017-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 125 mg Intravenous

Indications